Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) intends to subscribe for 25% equity of Chengdu VdTimes.

Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) announced that its wholly-owned subsidiary, Guizhou Sanli Pharmaceutical Co., Ltd. Health Management Limited (referred to as "Sanli Health"), intends to jointly increase the capital of Chengdu Dimensional Times Technology Co., Ltd. (referred to as "Chengdu Dimensional Times") with Hangzhou Eternal Prosperity Technology Development Co., Ltd. (referred to as "Eternal Prosperity"), Sichuan Yao Zunbao Supply Chain Management Partnership Enterprise (General Partnership) (referred to as "Yao Zunbao"), and Sichuan Xuan'an Technology Partnership Enterprise (Limited Partnership) (referred to as "Xuan'an Technology"). Sanli Health plans to subscribe for 25% equity of Chengdu Dimensional Time with its own funds of 20 million RMB.